Latest Emergent BioSolutions Stories
ReportsnReports.com offers Bronchopulmonary Dysplasia - Pipeline Review, H2 2014 and Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 new market reports.
DALLAS, May 21, 2014 /PRNewswire/ -- ReportsnReports.com offers "Vaccines: The End of Illness" and other vaccine market research reports focusing on vaccine technology,
ROCKVILLE, Md., April 8, 2014 /PRNewswire/ -- Biologics development and manufacturing services provider Omnia Biologics, Inc.
Reportbuyer.com just published a new market research report:
ANNAPOLIS, Md., Jan. 10, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has strengthened its research and development and program management functions with the addition of several new leadership appointments. Namely, Ms.
MERIDEN, Conn., Nov.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack.
- The act of sweetening by admixture of some saccharine substance.